The safety of subcutaneous implantable cardioverter defibrillator (S-ICD) recipients who lead active lifestyles and engage in recreational sports is unknown. We aimed to evaluate the association ...
aDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China bState Key Laboratory of Reproductive ...
Abstract: The advent of the sixth-generation (6G) networks presents another round of revolution for the mobile communication landscape, promising an immersive experience, robust reliability, minimal ...
Subcutaneous immunotherapy for cancer can cause many of the same side effects as intravenous (IV) immunotherapy because it involves the same medications. Injection site reactions are a common but ...
Abstract: It is becoming increasingly common for many oil-immersed power transformers (PTs) in many countries, including USA, to reach the end of their designed service life. Insulation issues ...
NEXT WEEK ARE NOW GOING TO BE DELAYED. I.V. FLUID IS LIKE A LIFELINE TO PATIENTS. THAT LIFELINE IS IN SHORT SUPPLY AND NOW IMPACTING PATIENTS WHO HAVE NON-EMERGENCY SURGERIES SCHEDULED AT MASS.
WVU Medicine has begun treating patients in the first clinical trial to explore the use of subcutaneous blinatumomab in patients with CD19-positive MPAL. West Virginia University (WVU) Health System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results